Biopharmas raising money in public or private financings, including: Aeterna Zentaris, Aptevo, Athenex, Citius, Diamedica, G1, Horizon, Painreform, Spectrum, Vistagen.

Med-tech firms raising money in public or private financings, including: Emergent Biosolutions, Medx Health, Veracyte.

Matterhorn Bioscience AG has launched to develop T-cell receptor therapies based on the power of MR1T cells that have been found to find and kill a range of tumors in various tissue organs.

Biopharmas raising money in public or private financings, including: Adaptive Phage, ARC, Emerald, Emergent, Gentibio, Immunic, Myovant, Nicox, Qualigen, Taysha, Tiziana.

Biopharmas in Asia-Pacific raising money in public or private financings, including: Cytodyn, Propanc.

Med-tech firms raising money in public or private financings, including: Avinger, Ra Medical Systems, Voiceitt.

Biopharmas raising money in public or private financings, including: Achieve, Allovir, Astrazeneca, Bryn, Emergent, Immunic, Nervgen, Nuview, Point, Salarius, Sonnet, Transgene.

Med-tech firms raising money in public or private financings, including: Vivoplex.

Biopharmas raising money in public or private financings, including: Advaxis, Aeterna, Arcturus, Checkmate, Freeline, Kymera, PMV, Qualigen, Tiziana, Vaxil, Vistagen.